Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Bielsa Marsol

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Reumatologia Clinica|July 29, 2011
[Dermatomyositis]Isabel Bielsa Marsol
European Journal of Dermatology : EJD|December 5, 2022
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?Gemma Melé-Ninot, Esther Serra-Baldrich, Jorge Spertino, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2023
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter studyMaría Castellanos-Gonzalez, Beatriz Butrón Bris, Isabel Bielsa Marsol, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 18, 2026
Phenotypes and clinical outcomes in children with moderate-to-severe atopic dermatitis across diverse ancestries: a Spanish multicenter observational study and cluster analysis (AD-SKINS Project)Eugeni Prat-Colilles, Adrià Plana-Pla, Asunción Vicente, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Reumatologia Clinica|July 29, 2011
[Dermatomyositis]Isabel Bielsa Marsol
European Journal of Dermatology : EJD|December 5, 2022
Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?Gemma Melé-Ninot, Esther Serra-Baldrich, Jorge Spertino, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2023
Predictive factors for anti-MDA5 antibody in patients with dermatomyositis: a retrospective multicenter studyMaría Castellanos-Gonzalez, Beatriz Butrón Bris, Isabel Bielsa Marsol, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 18, 2026
Phenotypes and clinical outcomes in children with moderate-to-severe atopic dermatitis across diverse ancestries: a Spanish multicenter observational study and cluster analysis (AD-SKINS Project)Eugeni Prat-Colilles, Adrià Plana-Pla, Asunción Vicente, et al.
Pageof 1